By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
India Times NowIndia Times NowIndia Times Now
Notification Show More
Font ResizerAa
  • India News
    India News
    Politics is the art of looking for trouble, finding it everywhere, diagnosing it incorrectly and applying the wrong remedies.
    Show More
    Top News
    The States Braces for Protests Over New COVID Rules
    August 29, 2021
    Two brothers died of heart attack
    October 5, 2025
    Clean energy at the core of Telangana transformation: Bhatti
    December 8, 2025
    Latest News
    Kerala elections: Chennithala alleges ‘deal’ between Pinarayi, Modi, Amit Shah to defeat Congress-led UDF
    March 23, 2026
    Telangana joins ‘Vahan’ platform, scraps 2% tax on second vehicle
    March 23, 2026
    CCB unearths fake government jobs racket, arrests a couple in Bengaluru
    March 23, 2026
    Kerala polls: CPI(M) slams UDF’s Ramesh Pisharody over Gaza stance; Thomas Isaac’s ‘joker’ jibe sparks row
    March 23, 2026
  • Technology
    TechnologyShow More
    Strengthening the Team: Thryve PR Onboards Pranjal Patil as PR Executive & Project Manager
    October 1, 2025
    How to Take the Perfect Instagram Selfie: Dos & Don’ts
    October 1, 2021
    Apple iMac M1 Review: the All-In-One for Almost Everyone
    Hands-On With the iPhone 13, Pro, Max, and Mini
    September 4, 2021
    Apple VS Samsung– Can a Good Smartwatch Save Your Life?
    August 30, 2021
  • Posts
    • Post Layouts
      • Standard 1
      • Standard 2
      • Standard 3
      • Standard 4
      • Standard 5
      • Standard 6
      • Standard 7
      • Standard 8
      • No Featured
    • Gallery Layouts
      • Layout 1
      • Layout 2
      • layout 3
    • Video Layouts
      • Layout 1
      • Layout 2
      • Layout 3
      • Layout 4
    • Audio Layouts
      • Layout 1
      • Layout 2
      • Layout 3
      • Layout 4
    • Post Sidebar
      • Right Sidebar
      • Left Sidebar
      • No Sidebar
    • Review
      • Stars
      • Scores
      • User Rating
    • Content Features
      • Inline Mailchimp
      • Highlight Shares
      • Print Post
      • Inline Related
      • Source/Via Tag
      • Reading Indicator
      • Content Size Resizer
    • Break Page Selection
    • Table of Contents
      • Full Width
      • Left Side
    • Reaction Post
  • Pages
    • Blog Index
    • Contact US
    • Search Page
    • 404 Page
    • Customize Interests
    • My Bookmarks
  • Join Us
Reading: Q3 results: Pharma stock in focus as revenue increases 45% YoY, check share price
Share
Font ResizerAa
India Times NowIndia Times Now
  • Finance ₹
  • India News
  • The Escapist
  • Entertainment
  • Science
  • Technology
  • Insider
Search
  • Home
    • India Times Now
    • Home 2
    • Home 3
    • Home 4
    • Home 5
  • Categories
    • Technology
    • Entertainment
    • The Escapist
    • Insider
    • Finance ₹
    • India News
    • Science
    • Health
  • Bookmarks
    • Customize Interests
    • My Bookmarks
  • More Foxiz
    • Blog Index
    • Sitemap
Have an existing account? Sign In
Follow US
Home » Blog » Q3 results: Pharma stock in focus as revenue increases 45% YoY, check share price
BusinessStartup

Q3 results: Pharma stock in focus as revenue increases 45% YoY, check share price

Times Desk
Last updated: January 29, 2026 8:18 am
Times Desk
Published: January 29, 2026
Share
SHARE


The stock’s 14-day relative strength index (RSI) is 30.63. For the uninitiated, a level above 70 is considered overbought or overvalued, and below 30 is defined as oversold or undervalued.

Mumbai:

Shares of pharma company Sudarshan Pharma Industries Ltd are in focus as the company has reported a 16 per cent increase in net sales to Rs 168.01 crore and a 51 per cent surge in net profit to Rs 4.36 crore for the third quarter of fiscal year 2026. Following this, the stock started the trading session in green at Rs 20.25 against the previous close of Rs 19.30 on the BSE. However, the stock slipped amid profit booking and market volatility and touched the low of Rs 18.50, its 52-week low. The 52-week high of the stock is Rs 43.14, hit on January 29, 2025. Last seen, the stock was trading at Rs 18.53, and the market cap of the company stood at Rs 445.94 crore. 

The stock is trading lower than the 5-day, 20-day, 50-day, 100-day and 200-day moving averages. 

The stock’s 14-day relative strength index (RSI) is 30.63. For the uninitiated, a level above 70 is considered overbought or overvalued, and below 30 is defined as oversold or undervalued.

According to BSE Analytics, the stock has delivered a return of 150.41 per cent in two years, but has corrected 57.05 per cent in one year.

Company forms subsidiary

In the quarter ending December 31, 2025, the company approved the formation of a wholly-owned subsidiary – Sudarshan Pharma Poland Limited Liability Company. Also, the board of directors of the company gave its consent to raise funds of up to Rs 1,500 crore by issuing Foreign Currency Convertible Bonds (FCCB). The company has also submitted its application with the BSE to obtain in-principle approval for the issue of FCCB up to the amount of USD 3,50,00,000.

Share market today

Meanwhile, benchmark equity indices Sensex and Nifty declined in early trade on Thursday after a two-day rally as investors turned cautious ahead of the Union Budget presentation on Sunday.

The 30-share BSE Sensex dropped 343.67 points to 82,001.01 during initial trade. The 50-share NSE Nifty edged lower by 94.2 points to 25,248.55.

ALSO READ | Forgot money in your old bank account? Here’s how you can claim it back in few minutes

(This article is for informational purposes only and should not be construed as investment, financial, or other advice.)





Source link

Tata Capital IPO GMP vs LG Electronics IPO GMP vs WeWork IPO GMP vs Anantam Highways Trust IPO GMP: Check all details
Silver Hallmarking: How to read a hallmark, charges and other details
This Chinese Province Says It Faked Fiscal Data for Several Years
LIC-back NBFC’s board to consider issuance of non-convertible debentures on November 6: Check details
Infosys, TCS and other IT stocks bleed after Anthropic’s new AI tool – Check share price
TAGGED:bseCheckfocusincreasesnsepharmaPricequarterly resultsresultsrevenuesharestockstock in focusSudarshan PharmaSudarshan Pharma share priceYoY
Share This Article
Facebook Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe
TelegramFollow

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
[mc4wp_form]
Popular News
EntertainmentMovieMusic

Bad Boy Billionaires India on Netflix: Fourth episode on Satyam Scandal finally releases after 5-year delay

Times Desk
Times Desk
December 31, 2025
Jagan slams CM Naidu over spurious liquor mafia in Andhra Pradesh
National-level workshop held in Annamayya
Two African women linked to Nigerian drug cartel apprehended by STF EAGLE Force
Maya Hawke, Stranger Things actor, marries Christian Lee Hutson in private Valentine’s Day ceremony
- Advertisement -
Ad imageAd image
Global Coronavirus Cases

Confirmed

0

Death

0

More Information:Covid-19 Statistics
© INDIA TIMES NOW 2026 . All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?